Treatment for aggressive spinal hemangioma
Part of Cancer clinical trials.
This study is testing a treatment for people with aggressive spinal hemangiomas—blood vessel growths in the spine that cause pain, weakness, or other symptoms. You may benefit if your hemangioma is causing problems and has been confirmed by imaging tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with an aggressive spinal hemangioma (a type of blood vessel growth in the spine) that is causing symptoms.
- Your condition must be confirmed by imaging tests like X-ray, MRI, CT scan, or angiogram.
- You have symptoms such as back pain, weakness, numbness, trouble walking, or problems with bowel or bladder control.
- You do not have a spinal hemangioma that was found by accident (incidental) and isn't causing any symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a treatment using a special gelled alcohol to shrink aggressive angiomas (abnormal blood vessel growths). It aims to see if the procedure is safe, feasible, and works well.
This trial tests a new drug called SYHA1813 for meningiomas (tumors in the brain's protective lining) that have come back or are growing after surgery and radiation. The goal is to see if this drug can help slow or stop tumor growth.
This trial studies whether a procedure that blocks the tumor’s blood supply (embolization) can help people with a typical meningioma that is growing or causing symptoms. It may help shrink or control the tumor by cutting off its main blood supply.
This study looks at babies with a type of birthmark called infantile hemangioma (including those that barely grow or have stopped growing). Researchers want to understand the risks and decide on the best treatment.
This Phase 1 study tests an advanced stem-cell treatment (hMSC-DNX2401) for recurrent high-grade glioma, including certain brain tumor types that come back. It aims to see if the treatment can be safely delivered and whether it can help control the tumor after standard therapies have already been tried.
This trial studies whether an add-on, minimally invasive procedure works better than standard care for a specific brain blood-vessel problem (CSH) that is larger than 10 mm. It may help reduce symptoms or prevent worsening, if you meet the size and location requirements.
Hear when a new Aggressive Spinal Hemangiomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.